Management of Clinical Cardiac Sarcoidosis Isolated to the Heart With Tumor Necrosis Factor–Alpha Inhibitors
TNF-ai treatment can improve cardiac inflammation on fluorodeoxyglucose positron emission tomography and reduce corticosteroid exposure in sarcoidosis isolated to the heart.
Authors
- Jana Lovell (ORCID: https://orcid.org/0000-0001-5086-8367)
- Nisha A. Gilotra (ORCID: https://orcid.org/0000-0002-4511-8008)
- Edward K. Kasper (ORCID: https://orcid.org/0000-0002-5730-5433)
- Jasmine Malhi
- Jonathan Chrispin (ORCID: https://orcid.org/0000-0002-7985-3019)
- Michelle Sharp (ORCID: https://orcid.org/0000-0002-1552-2579)
- Edward S. Chen
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.jaccas.2025.105906
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00